首页> 外文期刊>Journal of drugs in dermatology: JDD >Successful Treatment of Generalized Essential Telangiectasia With 6-Mercaptopurine
【24h】

Successful Treatment of Generalized Essential Telangiectasia With 6-Mercaptopurine

机译:用6-巯基嘌呤成功治疗广义必需的毛刺血症

获取原文
获取原文并翻译 | 示例
           

摘要

Generalized essential telangiectasia (GET) is a notoriously difficult to treat disorder with no current satisfactory treatments. This case and discussion report the use of 6-mercaptopurine (6-MP)as a successful treatment for GET. Moreover, we show that GET may represent a state of increased angiogenesis, a paradigm shift from the current understanding that these telangiectasias represent dilatations of only pre-existing vessels. This new view of GET may drive others to look at novel agents for treatment.
机译:广义必需的Telanciectasia(Get)是一种难以治疗无期令人满意的治疗的疾病。 这种情况和讨论报告使用6-巯基嘌呤(6-MP)作为获得的成功治疗。 此外,我们表明得到的可能代表增加血管生成的状态,从目前理解的范式转变,这些电信鳗代表只有预先存在的血管的膨胀。 这个新的可获得的新观点可能会驱使其他人看待待遇的新代理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号